Top Markets
Coin of the day
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
Clasificación en acciones #32816
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
Precio por acción
$2.22
Capitalización bursátil
$9.03M
Cambio (1 día)
-3.13%
Cambio (1 año)
-21.92%
País
JP
Comercio PhoenixBio Co., Ltd. (6190)

Categoría

Historial del precio de la acción de PhoenixBio Co., Ltd. (6190)
Precio más alto de cierre: $2.26 el 2026-08-01

Precio más bajo de cierre: $22.51 el 2016-03-01
Historial del precio de la acción de PhoenixBio Co., Ltd. desde 2016 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -11.29%
2025 45.96%
2024 -30.54%
2023 -37.47%
2022 10.54%
2021 -19.56%
2020 -25.90%
2019 13.30%
2018 -31.36%
2017 -30.45%
2016 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$514.52 30.99%
US
$986.61 50.90%
NL
$736.64 7.19%
CH
$1.07K -6.40%
KR
$255.50 13.38%
BE